微球大小对药物释放率有很重要的影响，人们认为可以改变其大小以建立一个药物释放符合需要能够控制药物释放的体系。
Microsphere size, which has a significant effect on drug release rate, can potentially be varied to design a controlled drug delivery system with desired release profile.
结论囊泡型磷脂凝胶作为一种新型给药系统，在控制药物释放、提高抗肿瘤活性、增加药物稳定性等方面显示独特的优势。
Conclusions As a new drug delivery system, VPG is advantageous in controlling drug release, enhancing the activity of anti-tumor drugs and improving the long term stability.
因此有必要开发具有较好稳定性的缓释栓剂，可以有效地控制药物释放速度，降低副反应：减少服药次数，提高病人顺应性。
It's necessary to develop a sustained release suppository with good stability to reduce the frequency of administration and improve patients' compliance.
对最终体系进行的体外药物布洛芬（IBU）的装载和释放测试表明，该体系在温度响应控制药物释放方面有着较大的潜在应用前景。
The in vitro test of IBU loading and release illustrated the system had a great potential use for thermo-responsive controlled drug-release.
NLC具有的特殊结构可以提高其载药能力和制剂的稳定性，能有效的控制药物的释放。
The special structure of NLC improves its drug-loading capacity and stability, and effectively controls the release of drugs.
利用微针阵列实行局部定时地释放药物、控制药量，微针阵列的研制是微驱动器的关键。
With the development of the Micro Electro-Mechanical System(MEMS), it becomes possible for microneedles array to strengthen the transdermal drug delivery.
利用微针阵列实行局部定时地释放药物、控制药量，微针阵列的研制是微驱动器的关键。
With the development of the Micro Electro-Mechanical System(MEMS), it becomes possible for microneedles array to strengthen the transdermal drug delivery.
应用推荐